lacosamide extended release (ADS-4101) / Supernus Pharma 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   19 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lacosamide extended release (ADS-4101) / Supernus Pharma
NCT05788159: An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic(PK)Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.

Not yet recruiting
1
16
RoW
Lacosamide Tablets, Lacosamide extended release tablets
Overseas Pharmaceuticals, Ltd., Beijing Capton Pharmaceutical Technology Development Co., LTD
Epilepsy
06/23
07/23

Download Options